The findings reveal that TGF-β1-enhanced phase separation of the chromatin-associated RBP hnRNP L promotes gene transcription and facilitates profibrotic phenotypes in lung myofibroblasts, suggesting a phase-separation-based therapeutic strategy.
Abstract
INTRODUCTION
Pulmonary fibrosis is an interstitial lung disease characterized by diverse etiologies and unknown mechanisms. Phase separation has been implicated in the development of numerous diseases, but its role in the pathogenesis of pulmonary fibrogenesis remains unclear. In this study, we explored whether heterogeneous nuclear ribonucleoprotein L (hnRNP L) can form phase-separation condensates that contribute to the progression of pulmonary fibrosis.
Methods
Pulmonary fibrosis was modeled in vitro using TGF-β1-treated fibroblasts and in vivo by intratracheal bleomycin administration in mice. Phase-separation formation was evaluated by droplet formation and fluorescence recovery after photobleaching experiments. Adeno-associated virus vectors overexpressing full-length hnRNP L or hnRNP L-Δ26-111 & 274-374 (truncation of amino acid fragments 26-111 and 274-374) were constructed and delivered into murine lungs using a Penn-Century MicroSprayer device. Micro-computed tomography imaging, forced vital capacity tests, hematoxylin and eosin staining, and Masson's trichrome staining were performed to assess the anti-fibrotic effect of disrupting hnRNP L phase separation. RNA-seq was employed to explore the underlying molecular targets of hnRNP L.
Results
In vivo and in vitro results revealed that the role of hnRNP L in promoting fibroblast differentiation depended on its phase separation, and the amino acid fragments 26-111 and 274-374 were essential to this process. Phenotypic, physiological, and histological analyses demonstrated that hnRNP L overexpression accelerated the development of pulmonary fibrogenesis. In contrast, truncated hnRNP L-Δ26-111 and 274-374 improved lung tissue structure and function and reduced collagen deposition by blocking hnRNP L phase separation. RNA-seq results showed that a total of 1,155 dysregulated genes (FDR < 0.05, |logFC| > 1) were detected after silencing hnRNP L using small interfering RNA (siRNA) in TGF-β1-treated MRC-5 cells. Most differentially expressed genes were related to lung fibrosis, including TGFBR1, CXCL8, WWTR1, FAP, VIM, α-SMA, and collagen. The RNA levels of these genes were evidently regulated by silencing or overexpressing hnRNP L. Notably, we observed that hnRNP L phase separation promoted histone modifications such as H3K27ac, H4K8la, H4K12la, and H4K16la, which are associated with active chromatin.
Discussion
Our findings reveal that TGF-β1-enhanced phase separation of the chromatin-associated RBP hnRNP L promotes gene transcription and facilitates profibrotic phenotypes in lung myofibroblasts, suggesting a phase-separation-based therapeutic strategy.
Conclusion
Blocking hnRNP L phase separation inhibited fibroblast-to-myofibroblast differentiation, attenuating pulmonary fibrogenesis. This study reveals a novel regulatory mechanism by which phase separation contributes to the development of pulmonary fibrosis.
Highlights What are the main findings? Chlorogenic acid prevents alveolar architecture collapse and reduces total cell infiltration in bleomycin-challenged mice. Chlorogenic acid administration significantly suppressed collagen deposition, TGF-β1 expression, and α-SMA-positive myofibroblast activation. What are the imp...
Juan Manuel Velázquez-Enríquez, Alma Aurora Ramírez-Hernández, Jovito Cesar Santos-Álvarez et al.· Advances in Respiratory Medi...· 0 citations
It is suggested that MAGI2 acts as a negative regulator of myofibroblast differentiation by stabilizing PTEN, whereas PREX2 is aberrantly expressed in the fibrotic milieu, negatively modulating MAGI2, thereby accelerating pulmonary fibrosis.
Yozo Sato, K. Kamio, Yasuhiro Terasaki et al.· American Journal of Physiolo...· 0 citations
A mannose-modified tobacco mosaic virus nanoparticle is developed, which targets and reprograms profibrotic macrophages to inhibit IPF and establishes plant viral nanoparticles as a macrophage reprogramming strategy with therapeutic potential for organ fibrosis.
Jiaodan Jin, Ren Xu, H. Fu et al.· Journal of materials chemist...· 0 citations
IL-4Rα-mediated signaling is identified as a promising intervention point in pulmonary fibrosis and support further investigation of dupilumab as a candidate therapy for fibrotic lung diseases.
Qi Chen, Yu-Pei Zhang, Shi-Yang Wang et al.· Lung· 0 citations
Background Idiopathic Pulmonary Fibrosis (IPF) is a fatal chronic lung disease with limited therapeutic options. While alveolar epithelial injury and fibroblast activation are well-studied, endothelial-mesenchymal transition (EndoMT) is emerging as a critical pathogenic mechanism. The regulatory role of exosomal miRNAs...
J. Pang, Jia-Rui Shen, Wei Yang et al.· bioRxiv· 0 citations
In bleomycin-treated mice, formononetin improved lung function, attenuated histopathological fibrosis and collagen deposition, and reduced pulmonary inflammation, which support further investigation of formononetin as a potential candidate for PF treatment.
Yong-Ping Wang, Xue-Ze Liu, Hao Song et al.· Journal of Thoracic Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.